Corporate Overview

A Leading Player of Intervention of Heart Diseases & Neurovascular Diseases

Peijia Medical Limited was established in the Cayman Islands in 2012 with headquarter in Suzhou. The Company focuses on the high-growth interventional procedural medical device market in China, and aims to become a world-renowned medical device platform that provides total treatment solutions for structural heart and neurovascular diseases. Peijia has established comprehensive product development infrastructure and a vibrant product pipeline with 6 registered products and 20 product candidates in various stages of development.

Aims to Become a World-renowned Medical Device Platform that Provides
Total Treatment Solutions for Structural Heart and Neurovascular Diseases

Innovation forms Peijia’s foundation. The Company adopts avant-garde technologies to offer advanced therapies and increase accessibility of treatment. The Company strives for the benefit of cardiovascular and cerebrovascular health.


Devoted to heart, Care for life


To fulfill the clinical requirements with innovative technologies, and to improve the well-being of humans with a cautious attitude towards life